Education
About Us
Working with TipRanks
Follow Us
Hca Healthcare (HCA)
:HCA
HCA Analyst Ratings
Moderate Buy
8 Buy
4 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
HCA Stock 12 Month Forecast
Average Price Target
$385.30
▲(0.95%Upside)
| Highest Price Target$444.00 | Average Price Target$385.30 | Lowest Price Target$336.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Leerink Partners
$390→$420
Buy
10.05%
Upside
Reiterated
06/04/25
Barclays
$366→$416
Buy
9.00%
Upside
Reiterated
06/03/25
Wells Fargo
$320→$385
Hold
0.88%
Upside
Upgraded
05/29/25
Cantor Fitzgerald
$444
Buy
16.33%
Upside
Reiterated
05/28/25
Bank of America Securities
―
Buy
―
Reiterated
05/19/25
Truist Financial
$390
Buy
2.19%
Upside
Reiterated
04/28/25
Morgan Stanley
$355
Hold
-6.99%
Downside
Reiterated
04/28/25
KeyBanc
$370
Buy
-3.06%
Downside
Reiterated
04/28/25
TD Cowen
$377→$361
Buy
-5.41%
Downside
Reiterated
04/28/25
RBC Capital
$376
Buy
-1.48%
Downside
Reiterated
04/27/25
Robert W. Baird
$396→$336
Hold
-11.96%
Downside
Downgraded
04/14/25
Guggenheim
―
Hold
―
Initiated
04/08/25
Mizuho Securities
$425
Buy
11.36%
Upside
Reiterated
02/27/25
Analysts Are Bullish on Top Healthcare Stocks: HCA Healthcare (HCA), Kura Oncology (KURA)We hosted a Fireside chat with HCA CFO Michael Marks. Key takeaways from our call include: 1) the outlook in Washington was a key investor focus, 2) HCA believes 2025 guidance fully captures all potential outcomes, 3) base underlying demand trends remain solid and pricing should continue to be strong in 2025, and 4) HCA’s strong balance sheet and cash flow continue to provide financial optionality going forward. We continue to believe earnings visibility remains high for 2025. We are reiterating our Outperform rating. Key Topic. The Washington outlook was a key focus given the potential for healthcare to be a pay-for in the upcoming tax reforms.
J.P. Morgan
$380→$360
Hold
-5.68%
Downside
Reiterated
01/31/25
Jefferies
$400
Buy
4.81%
Upside
Reiterated
01/29/25
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Leerink Partners
$390→$420
Buy
10.05%
Upside
Reiterated
06/04/25
Barclays
$366→$416
Buy
9.00%
Upside
Reiterated
06/03/25
Wells Fargo
$320→$385
Hold
0.88%
Upside
Upgraded
05/29/25
Cantor Fitzgerald
$444
Buy
16.33%
Upside
Reiterated
05/28/25
Bank of America Securities
―
Buy
―
Reiterated
05/19/25
Truist Financial
$390
Buy
2.19%
Upside
Reiterated
04/28/25
Morgan Stanley
$355
Hold
-6.99%
Downside
Reiterated
04/28/25
KeyBanc
$370
Buy
-3.06%
Downside
Reiterated
04/28/25
TD Cowen
$377→$361
Buy
-5.41%
Downside
Reiterated
04/28/25
RBC Capital
$376
Buy
-1.48%
Downside
Reiterated
04/27/25
Robert W. Baird
$396→$336
Hold
-11.96%
Downside
Downgraded
04/14/25
Guggenheim
―
Hold
―
Initiated
04/08/25
Mizuho Securities
$425
Buy
11.36%
Upside
Reiterated
02/27/25
Analysts Are Bullish on Top Healthcare Stocks: HCA Healthcare (HCA), Kura Oncology (KURA)We hosted a Fireside chat with HCA CFO Michael Marks. Key takeaways from our call include: 1) the outlook in Washington was a key investor focus, 2) HCA believes 2025 guidance fully captures all potential outcomes, 3) base underlying demand trends remain solid and pricing should continue to be strong in 2025, and 4) HCA’s strong balance sheet and cash flow continue to provide financial optionality going forward. We continue to believe earnings visibility remains high for 2025. We are reiterating our Outperform rating. Key Topic. The Washington outlook was a key focus given the potential for healthcare to be a pay-for in the upcoming tax reforms.
J.P. Morgan
$380→$360
Hold
-5.68%
Downside
Reiterated
01/31/25
Jefferies
$400
Buy
4.81%
Upside
Reiterated
01/29/25
Best Analysts Covering HCA Healthcare
1 Month
xxx
Success Rate
25/36 ratings generated profit
Average Return
+4.36%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 69.44% of your transactions generating a profit, with an average return of +4.36% per trade.
3 Months
xxx
Success Rate
28/38 ratings generated profit
Average Return
+7.84%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 73.68% of your transactions generating a profit, with an average return of +7.84% per trade.
1 Year
Success Rate
18/19 ratings generated profit
Average Return
+26.86%
reiterated a buy rating last month
Copying Ben Hendrix's trades and holding each position for 1 Year would result in 94.74% of your transactions generating a profit, with an average return of +26.86% per trade.
2 Years
xxx
Success Rate
41/41 ratings generated profit
Average Return
+51.91%
reiterated a xxx
rating 2 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +51.91% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
HCA Analyst Recommendation Trends
Rating
Feb 25
Mar 25
Apr 25
May 25
Jun 25
Strong Buy
1
0
0
0
0
Buy
16
18
13
15
15
Hold
9
5
3
5
5
Sell
1
1
1
0
0
Strong Sell
0
0
0
0
0
total
27
24
17
20
20
Each month's total comprises the sum of three months' worth of ratings.
HCA Financial Forecast
HCA Stock Forecast FAQ
What is HCA’s average 12-month price target, according to analysts?
Based on analyst ratings, Hca Healthcare’s 12-month average price target is 385.30.
What is HCA’s upside potential, based on the analysts’ average price target?
Hca Healthcare has 0.95% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is HCA a Buy, Sell or Hold?
Hca Healthcare has a consensus rating of Moderate Buy which is based on 8 buy ratings, 4 hold ratings and 0 sell ratings.
What is Hca Healthcare’s price target?
The average price target for Hca Healthcare is 385.30. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $444.00 ,the lowest forecast is $336.00. The average price target represents 0.95% Increase from the current price of $381.66.
The highest analyst price target is $444.00 ,the lowest forecast is $336.00. The average price target represents 0.95% Increase from the current price of $381.66.
What do analysts say about Hca Healthcare?
Hca Healthcare’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 12 Wall Streets Analysts.
How can I buy shares of HCA?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.